Grundinformationen
- Standard-SMILES
O=C(O)c1ccc(OC2CC2)cc1- InChIKey
VUANULXCHKBPDD-UHFFFAOYSA-N- Summenformel
- C10H10O3
- Durchschnittliche Molmasse
- 178,18 g/mol
- Monoisotopische Masse
- 178,06299418
Namen und Bezeichner
- Bevorzugter Name
- 4-Cyclopropoxybenzoic acid
- IUPAC
- 4-cyclopropyloxybenzoic acid
- Englischer Name
- 4-Cyclopropoxy-benzoic acid
- Summenformel
- C10H10O3
- Molmasse
- 178.18
Namen und Synonyme
4-CYCLOPROPOXYBENZOIC ACIDRefChem:522373826-272-862577-90-64-cyclopropyloxybenzoic acid4-Cyclopropoxy-benzoic acidMFCD170004694-(Cyclopropoxy)benzoic acidBenzoic acid, 4-(cyclopropyloxy)-4-(Cyclopropyloxy)benzoic acid4 -cyclopropyloxybenzoic acidSCHEMBL1977190
Weitere Namen anzeigen
4-cyclopropoxybenzenemacetic acid
4-CYCLOPROPOXYBENZOICACIDDTXSID00614126VUANULXCHKBPDD-UHFFFAOYSA-NMCA57790ZB1110AKOS023798242MB29027AS-83145
Datenbank-Bezeichner
- CAS
62577-90-6- PubChem CID
- 21452864
- DTXSID
DTXSID00614126- EC Number
- 826-272-8
Eigenschaften
Berechnete Struktureigenschaften
- XLogP
- 2,5
- Polarare Oberfläche (TPSA)
- 46,5 Ų
- H-Brücken-Donoren
- 1
- H-Brücken-Akzeptoren
- 3
- Frei drehbare Bindungen
- 3
- Schwere Atome
- 13
- Formalladung
- 0
- Komplexität
- 190
Physikochemische Eigenschaften
- Schmelzpunkt
- 161 · 161-162 °C
- Siedepunkt
- 325.5 · 325.5±15.0 °C(Predicted)
- Dichte
- 1.317 · 1.317±0.06 g/cm3(Predicted)
- pka
- 4.47 · 4.47±0.10(Predicted)
Sicherheit und Regulatorisches
GHS-Klassifizierung
GHS Classification
Warning
H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]
P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 2 reports by companies from 2 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Gefahrenhinweise
Hazard Classes and CategoriesAcute Tox. 4 (100%)
Sicherheitsdaten
- hs_code
- 2918999090
Chemie und Industrie
Anwendungen
Verwenden4-Cyclopropyloxybenzoic Acid is used in the preparation of imidazobenzazepine derivatives as DGAT-1 inhibitors which is useful in the treatment of diabetes and obesity.
Anbieter28 Anbieter
毕佳索(上海毕得医药科技股份有限公司)400-6005915 · [email protected]
上海毕得医药科技股份有限公司400-1647117 13681763483 · [email protected]
Suzhou ARTK Medchem Co., Ltd.+86-18168183658 · [email protected]
安耐吉化学&3A(安徽泽升科技有限公司)021-58432009 400-005-6266 · [email protected]
苏州施亚生物科技有限公司17715136450 · [email protected]
南京药石科技股份有限公司4000255188 · [email protected]
苏州施亚生物科技有限公司86(512)5235 8471 17715136450 · [email protected]
Moxin Chemicals+86-17320513646 +86-17320513646 · [email protected]
杭州迈世腾药物科技有限公司0571-82896630 18969958410 · [email protected]
湖南氩氡医药科技有限公司13764359345 · [email protected]
济宁横渠生物技术有限公司18118824509 · [email protected]
威海怀信生物科技有限公司15662379806 · [email protected]
上海佰安麦材料科技有限公司13656718387 · [email protected]
郑州阿尔法化工有限公司0371-53778726 18003825608 · [email protected]
常州合晶化工有限公司85528066 13775048983 · [email protected]
江阴康源生物医药科技有限公司0510-86010668 · [email protected]
华诺医药科技(广西)有限公司13005928603 · [email protected]
聿锦(天津)科技有限公司13370351217 kungfu1217@1 · [email protected]
福州福康医药科技有限公司18150835816
上海思阔化学科技有限公司021-33758897 · [email protected]
江苏艾康生物医药研发有限公司025-58859352 17714375163 · [email protected]
湖北摩科化学有限公司18627753421; 18627756402 · [email protected]
上海康恩博医药科技有限公司17510465506 · [email protected]
Shanghai Scochem Technology Co., Ltd+86-021-33758897 +86-13701882790 · [email protected]
上海捷世凯生物科技有限公司021-57520305 13795461237 · [email protected]
Guangzhou CATO Research Chemicals Inc.+86-020-81960175-617 18520203721 · [email protected]
珠海奥博凯生物医药技术有限公司400-0628126 · [email protected]
上海皓鸿生物医药科技有限公司400-8210725 4008210725 · [email protected]
Zugehörige Reaktionen
6
Verknüpfte Notizen
Wird geladen…